Clinical Trials Logo

Filter by:
NCT ID: NCT04489901 Completed - Pregnancy Related Clinical Trials

Stria Gravidarum and Olive Oil for Pregnancy Women

Start date: February 15, 2019
Phase: N/A
Study type: Interventional

The aim of this study was to investigate the clinical efficacy of olive oil on the severity and progression of striae gravidarum. This randomized controlled clinical trial included 156 primipara women who were early third trimester. They were randomly allocated into two groups: an experimental group and a control group. Women in the experimental group applied olive oil to their abdomen twice a day in the morning and evening. The control group had no intervention.

NCT ID: NCT04489537 Terminated - Clinical trials for Hemophilia A With Inhibitor

Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B

Start date: May 4, 2021
Phase: Phase 3
Study type: Interventional

The purpose of the trial is to evaluate the safety and efficacy of MarzAA for on-demand treatment and control of bleeding episodes in hemophilia A or B patients with inhibitors compared with their standard of care (SOC).

NCT ID: NCT04488991 Recruiting - Cervical Cancer Clinical Trials

Nabothian Cyst Protects or Facilitates Against Cervical Cancer

Start date: July 23, 2020
Phase:
Study type: Observational

Aim of the study to asses the realition between HPV infection, Nabothian Cyst and Cervical Intraepithelial lesions or Cervical Cancer

NCT ID: NCT04488809 Enrolling by invitation - Sedentary Behavior Clinical Trials

Comparison the Effects of Deep Water Running and Treadmill Running

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to compare the effectiveness of different exercise programs as 'Deep Water Running' and 'Treadmill Running' in sedentary young adults.

NCT ID: NCT04488575 Terminated - Covid19 Clinical Trials

Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection

Start date: August 26, 2020
Phase: Phase 2
Study type: Interventional

Evelo will investigate the safety and efficacy of EDP1815 in the treatment of patients hospitalized with SARS-CoV-2 Infection

NCT ID: NCT04487873 Completed - Covid19 Clinical Trials

COVID-19 Phobia in Patients With Bronchiectasis During Covid-19 Pandemic

Start date: July 23, 2020
Phase:
Study type: Observational

In the literature, there are no studies evaluating COVID-19 phobia, quality of life, health anxiety, physical activity level and quality of sleep in patients with bronchiectasis during COVID-19 pandemic. The investigators will evaluate these parameters in patients with bronchiectasis and compare the findings of healthy individuals during COVID-19 pandemic

NCT ID: NCT04487535 Completed - Clinical trials for Total Knee Arthroplasty

The Relationship Between Preoperative Serum Cytokine Level and Lenght of Stay in Hospital, Postoperative Pain Intensity, Functional Status, Joint Position Sense and X Ray Findings

Start date: December 1, 2018
Phase: N/A
Study type: Interventional

Serum cytokines was assosiated with symptoms and progression of osteoartritis. It is unknown whether these cytokines have a predictive role on severity of symptoms after total knee arthroplasty (TKA) or not. The aim of this study is to investigate the relationships between the preoperative serum cytokine level (SCL) and lenght of stay in hospital, postoperative pain intensity, functional status, joint position sense and X ray. Grade 4 osteoartritis degeneration who intern the hospital for total knee arthroplasty surgery. Serum Cytokine Levels (IL-6, TNFα, IL-1β) will be assessed before surgery. Pain intensity at rest/activity and valgite angle will be evaluated before surgery, postoperative 72 hour and postoperative 6 weeks. Functional status and joint position sense will be assessed before surgery and 6 weeks after surgery. Lenght of stay in hospital (LOS) will be recorded.

NCT ID: NCT04487366 Enrolling by invitation - Clinical trials for Anesthesiology Training

Single and Double Operator Techniques in Ultrasound-guided Peripheral Nerve Block Learning Curve

Start date: July 1, 2020
Phase: N/A
Study type: Interventional

Aim of this study is to compare learning curves of single(1- Jedi grip: Pappin and Christie/ 2- Bedforth/ 3- on lock: Gupta and Berrill) and double operator ultrasound-guided peripheric nerve block techniques on a home-made gelatin-based phantom model.

NCT ID: NCT04487353 Completed - Clinical trials for Educational Problems

Teaching the Mechanism of Birth by Virtual Reality

Start date: June 15, 2021
Phase: N/A
Study type: Interventional

With the virtual birth application, - Learning the physiology and mechanism of birth, - To monitor the progress of birth and to understand deviations from normal, - Learning normal birth, - It will provide the opportunity to see all the emergencies that may be encountered at birth and besides these, the information will be remembered for a long time. In this way, the effectiveness of virtual birth in midwifery education will be evaluated. Teaching the birth, which is one of the cornerstones of midwifery education and where the students find the opportunity to practice clinically, with virtual reality application, will minimize clinical application errors and will provide early diagnosis of adverse conditions such as fetal presentation and placental anomalies that may occur at birth. It is an up-to-date and important subject that will enable them to see the stages of birth in three dimensions with the virtual delivery application without any obstacle in midwifery education, the birth process, the birth mechanisms of the baby from the birth canal.

NCT ID: NCT04487080 Active, not recruiting - Clinical trials for Carcinoma, Non-Small-Cell Lung

A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

MARIPOSA
Start date: September 30, 2020
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy of the amivantamab and lazertinib combination, compared with osimertinib, in participants with epidermal growth factor receptor (EGFR) mutation (Exon 19 deletions [Exon 19del] or Exon 21 L858R substitution) positive, locally advanced or metastatic non-small cell lung cancer (NSCLC).